克拉夫兰酸减轻了可卡因使用障碍患者的可卡因渴望
Mary F Morrison1, Ronan Cunningham2, M Ingre Walters3
1Morrison, Department of Psychiatry, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania; Department of Psychiatry, Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.
Psychopharmacology bulletin
|March 13, 2026
概括
克拉酸 (CLAV) 对可卡因使用障碍患者来说是安全的,即使继续使用可卡因. 在这个人群中,500毫克的CLAV剂量也减少了可卡因的渴望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
背景情况:
- 可卡因使用障碍 (CUD) 是一个重要的公共卫生问题.
- 现有的CUD治疗方法的疗效有限.
- GLT-1 (细胞谷氨酸转运体) 调节器代表了一个潜在的治疗途径.
研究的目的:
- 评估克拉夫兰酸 (CLAV) 在患有CUD的个体中的安全性和耐受性.
- 为了确定CLAV是否可以安全地与持续使用可卡因联合使用.
- 评估CLAV对可卡因渴望的影响.
主要方法:
- 一个随机的,安慰剂控制的,交叉住院患者研究.
- 参与者接受了口服CLAV (250毫克,500毫克,750毫克) 或安慰剂,与静脉注射可卡因结合使用.
- 通过生命体征,心电图,瞳孔直径和不良事件来评估安全性.
- 用可卡因渴望问卷-简要来测量可卡因渴望.
主要成果:
- 没有观察到临床显著的药物或与剂量相关的生命体征,心电图或瞳孔直径的变化.
- CLAV通常耐受良好,具有轻度至中度,短暂的不良事件,主要是胃肠道.
- 克拉维500毫克在减少可卡因渴望方面显示出很大的效果大小 (科恩d=1.25).
结论:
- 克拉酸 (CLAV) 在患有CUD的个体中是安全的,并且可以很好地容忍,即使与持续使用可卡因相结合.
- CLAV,特别是500毫克,在减少可卡因渴望方面表现有前途.
- 进一步研究CLAV作为CUD潜在治疗方法是有必要的.
相关概念视频
Drug Dependence
1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
Adrenergic Agonists: Indirect-Acting Agents
2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K


